We previously established pancreatic cancer (PaCa) cell lines resistant to gemcitabine and found that the activity of nuclear factor κB (NF-κB) was enhanced upon the acquisition of gemcitabine resistance. Here, NFKB1 is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.